Series A & B Funding Strategies for HealthTech

Table of Contents

Securing Series A and B funding is a defining moment for HealthTech startups. These funding rounds go beyond raising capital. They prove your business model, scale operations, and help attract the right partners.

This renewed momentum is evident in 2024, as healthcare startups on Carta raised $23 billion across 1,387 rounds. Such scale demonstrates ongoing investor commitment to digital health and Series A/B growth. For founders, high overall deal counts raise the bar for strategic differentiation.

This article unpacks the current funding landscape, what investors expect at each stage, and actionable strategies for navigating Series A and B rounds in HealthTech.

Understanding HealthTech Series A & B Funding

HealthTech Series A funding is typically the first major institutional round, where startups move from validation to scaling. Series B is about accelerating growth, expanding into new markets, and deepening product capabilities.

Securing Series A and B funding is a defining moment for HealthTech startups. These funding rounds go beyond raising capital. They prove your business model, scale operations, and help attract the right partners.

• Define key metrics
• Network with relevant investors
• Prepare documentation
• Present a strong pitch deck
• Demonstrate clinical and regulatory progress

Despite global economic headwinds, HealthTech remains a magnet for capital. Amid capital inflow, 38% of new healthcare investment targets AI-enabled technology. This allocation reflects investor confidence in automation and data-driven platforms.

Founders can strategically focus on AI integration to appeal to Series A/B backers. In the first half of 2025, top startups like Medi Builder ($343.2M total funding), Doctolib ($815M), and Ro ($38M) have shown that investors are backing platforms with real-world impact and scalable models. Series A and B rounds are increasingly competitive, with investors prioritizing:

• Clinical validation and regulatory progress
• AI and data-driven solutions
• Partnerships with payers, providers, and pharma
• Clear go-to-market and commercialization strategies

Case Studies

Startups like yours already closed their rounds with us.

Founders across every stage and industry. Here's what it took.

• Raised $7.6M for Swiipr Technologies
• Raised $0.5M for Ap Tack
• Raised €0.5M for Ivent Pro

Read their stories →

What Investors Expect at Series A

For healthcare tech startups, investors want evidence that your product solves a real healthcare problem, with paying customers, high user engagement, and positive clinical outcomes.

1. Demonstrated Product-Market Fit

Investors want evidence that your product solves a real healthcare problem, with paying customers, high user engagement, and positive clinical outcomes. Case studies, published data, and strong retention rates are key.

2. Clinical and Regulatory Traction

For a health tech startup, clinical validation includes peer-reviewed studies, pilot results, or real-world evidence.

• Regulatory progress: FDA/CE clearances, HIPAA compliance, or a clear regulatory roadmap.

3. Scalable Technology

• Cloud-based, interoperable, and secure platforms.
• AI/ML capabilities that drive value and differentiation.

Infrastructure Integration as a Series A Differentiator

Building on scalable technology, founders should prioritize integrating their solutions directly into clinical workflows and provider operations. This approach demonstrates real-world utility, reduces friction for adoption, and aligns with investor expectations for measurable impact.

Solutions embedded within electronic health records or staffing systems stand out against standalone apps, increasing the likelihood of Series A funding success. Investors view infrastructure integration as a signal of operational maturity and market readiness.

4. Go-to-Market Strategy

• Defined sales channels (B2B, B2C, enterprise, payer partnerships).
• Early revenue and a repeatable sales process.
• Strategic partnerships with health systems, payers, or pharma.

5. Strong Team

A founding team with healthcare, tech, and business expertise. Investors also look for advisors with clinical or regulatory backgrounds.

What Investors Expect at Series B

For healthcare tech startups, a proven revenue model is essential. Consistent, growing revenue streams (often $3M–$10M+ ARR; Annual Recurring Revenue).

1. Proven Revenue Model

Consistent, growing revenue streams (often $3M–$10M+ ARR; Annual Recurring Revenue). A clear road to revenue for health tech startups is essential, including high customer retention and expansion within accounts.

• High customer retention and expansion within accounts.

2. Market Expansion

• Plans to enter new markets or verticals (e.g., new geographies, payer segments, or care settings).
• Evidence of scalable operations and infrastructure.

3. Product Depth and Differentiation

• Expanded product offerings or deeper integration with existing healthcare workflows.
• Defensible IP, proprietary data, or exclusive partnerships.

4. Operational Excellence

• Robust financial controls, compliance, and reporting.
• Ability to recruit and retain top talent as the company scales.

5. Clear Path to Profitability or Exit

• Defined milestones for future rounds, acquisition, or IPO.
• Demonstrated interest from strategic partners or acquirers.

To frame the scale of Series B opportunities, an expanded sector index now includes 34 companies with $98 billion market cap. This growth highlights how successful B-stage startups rapidly join major industry leaders.

Key Funding Strategies for HealthTech Series A & B

For HealthTech Series A funding, building early relationships with investors is crucial. Start networking with Series A/B investors well before you need capital.

1. Build Early Relationships with Investors

Start networking with Series A/B investors well before you need capital. Attend industry events, join accelerator demo days, and leverage introductions from angels or seed investors. Investors like Sequoia, Greylock, and specialized HealthTech funds are active in 2025.

2. Leverage Strategic Partnerships

For healthcare startup funding, partnerships with hospitals, payers, pharma, or tech giants (like Oracle Health or AWS) can provide validation, pilot opportunities, and even co-investment.

Partnerships with hospitals, payers, pharma, or tech giants (like Oracle Health or AWS) can provide validation, pilot opportunities, and even co-investment. These relationships often accelerate due diligence and open doors to new customers.

3. Showcase Clinical and Economic Impact

Quantify your impact, reduced hospitalizations, improved outcomes, or cost savings. For example, CarePredict’s AI reduced hospitalizations by 39% and falls by 69%, helping secure their $29M round.

Shift from Standalone Apps to Workflow Integration

Beyond showcasing impact, founders should consider pivoting from standalone applications to platforms embedded in clinical workflows. Embedding technology within provider operations or electronic health records increases adoption rates and operational relevance. Investors increasingly favor solutions that integrate seamlessly into healthcare environments, viewing them as more scalable and sustainable. This shift can significantly improve Series A funding prospects.

4. Strengthen Regulatory and Compliance Readiness

Demonstrate regulatory progress and a clear plan for ongoing compliance. Investors want to see that you can navigate complex healthcare rules and scale safely.

5. Optimize Your Data Story

Investors want to see robust data on user engagement, clinical outcomes, and ROI for customers. Use dashboards, case studies, and third-party validation to make your metrics stand out.

6. Plan Your Use of Funds

Be specific about how Series A/B capital will drive growth—product development, hiring, market expansion, or regulatory milestones. Tie funding to clear, measurable objectives.

7. Prepare for Rigorous Due Diligence

Expect deep dives into your tech stack, clinical data, financials, and compliance. Have documentation ready and be transparent about risks and mitigation plans.

These relationships often accelerate due diligence and open doors to new customers, which is crucial for successful healthtech funding.

Standalone Apps vs. Workflow-Embedded Platforms

The Series A & B Process: Step-by-Step

The Series A & B process is a critical part of healthcare startup funding. Audit your metrics, regulatory status, and product roadmap.

1. Pre-Raise Preparation

• Audit your metrics, regulatory status, and product roadmap.
• Identify target investors and warm up relationships.
• Refine your pitch deck, focus on traction, impact, and scalability.

2. Investor Outreach

• Use a targeted list of HealthTech VCs and growth investors.
• Leverage introductions from angels, advisors, or accelerators.
• Attend industry conferences and demo days.

3. Pitching and Negotiation

• Highlight your unique value proposition, clinical data, and go-to-market strategy.
• Be ready for multiple meetings, technical deep dives, and negotiation on terms.

4. Due Diligence

• Provide access to data rooms with clinical, financial, and operational details.
• Address questions on IP, compliance, and competitive landscape.

5. Closing and Post-Investment

• Finalize legal documents, board structure, and reporting requirements.
• Set up regular investor updates and leverage their networks for growth.

Real-World Examples: Series A & B in Action

• QuantHealth ($15M Series A): This health tech firm offers an AI-powered platform for clinical trial simulation, backed by Bertelsmann Investments and Pitango HealthTech.
• Carrum Health ($45M Series B): Bundled care platform for employers, funded by Omers Growth Equity and Tiger Global. Focused on scaling oncology and surgical care offerings.
• CarePredict ($29M Series A-3): Senior care AI platform, backed by SV Health Investors and Aspire Healthtech. Funding accelerates adoption and product innovation.
• CureBay (Series B): This healthcare tech company is a leading Indian digital health platform, backed by Elev8 Venture Partners and Lightrock India.

For instance, WELL achieved $919.7 million annual revenue in 2024, marking 19% year-over-year growth. This milestone highlights how Series A/B investments can translate into substantial expansion. WELL’s trajectory demonstrates the sector’s potential despite regional funding challenges.

Common Mistakes to Avoid

• Weak clinical validation: Investors want hard evidence, not just pilot anecdotes.
• Unclear regulatory plan: Failing to address compliance can kill deals.
• Overly broad focus: Trying to serve too many markets or use cases dilutes your story.
• Underestimating capital needs: Be realistic about the resources required for growth.
• Ignoring operational risks: Investors expect a plan for scaling people, processes, and compliance.

Global Trends: HealthTech Series A & B in 2025

Healthcare tech companies such as QuantHealth and Basys.ai are raising capital for AI-driven solutions in clinical trials and payer automation.

Yet, in Canada, venture funding dropped 18% in 2024, totaling $700 million across 287 deals. This highlights a region-specific challenge contrasting with growth trends elsewhere.

• International Expansion: Series B rounds often fuel entry into new geographies, as seen with platforms like Sami in Brazil and CureBay in India.
• Strategic Acquisitions: Larger health tech firms are acquiring Series B startups to accelerate innovation and expand service lines.
• Government and Corporate Funding: Startups are tapping into government-backed funds and industry partnerships to complement VC capital.

How to Stand Out: Tips from Top Founders

For any health tech startup, focus on clinical outcomes: publish your results and seek third-party validation.

• Focus on Clinical Outcomes: Publish your results and seek third-party validation.
• Build a Diverse Team: Investors value teams with clinical, technical, and commercial expertise.
• Invest in Customer Success: High retention and expansion rates signal product-market fit.
• Stay Agile: Be ready to pivot based on feedback from customers and investors.
• Leverage Thought Leadership: Share insights at industry events and in publications to build credibility.

Conclusion

Navigating HealthTech Series A funding and Series B rounds requires a clear strategy and understanding of investor expectations. As the global HealthTech market continues to evolve, founders who proactively address investor expectations and build sustainable, evidence-driven businesses will be best positioned for long-term success.

As the global HealthTech market continues to evolve, founders who proactively address investor expectations and build sustainable, evidence-driven businesses will be best positioned for long-term success. Whether you’re preparing for your first institutional round or planning a major expansion, a clear funding strategy and the right partners can make all the difference.

Qubit Capital supports HealthTech founders through every stage of Series A and B fundraising. Our team brings deep expertise to every stage of healthtech funding, from refining your pitch and connecting with the right investors to navigating due diligence and scaling operations. Explore our startup services now!

Key Takeaways

• Series A and B funding are about scaling validated HealthTech solutions, not just raising capital.
• Investors expect clinical validation, regulatory readiness, scalable tech, and a clear go-to-market strategy.
• Strategic partnerships and strong data on outcomes and ROI are essential for standing out.
• Prepare for rigorous due diligence and be transparent about risks and plans for growth.
• Global trends in 2025 favor AI, international expansion, and government-corporate collaboration.